Zuardi AW - Search Results

1

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.

de Faria SM, de Morais Fabrício D, Tumas V, Castro PC, Ponti MA, Hallak JE, Zuardi AW, Crippa JAS, Chagas MHN. de Faria SM, et al. Among authors: zuardi aw. J Psychopharmacol. 2020 Feb;34(2):189-196. doi: 10.1177/0269881119895536. Epub 2020 Jan 7. J Psychopharmacol. 2020. PMID: 31909680 Clinical Trial.

2

Olanzapine for recurrent aggression in a patient with temporal lobe epilepsy who had temporal lobectomy.

Hallak JE, Dursun SM, Guarnieri R, Almeida E, Rezeck K, Crippa JA, Sakamoto AC, Zuardi AW, Deakin JF. Hallak JE, et al. Among authors: zuardi aw. J Psychopharmacol. 2003 Sep;17(3):350-1. doi: 10.1177/02698811030173020. J Psychopharmacol. 2003. PMID: 14513930

3

Effects of cannabidiol (CBD) on regional cerebral blood flow.

Crippa JA, Zuardi AW, Garrido GE, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JE, McGuire PK, Filho Busatto G. Crippa JA, et al. Among authors: zuardi aw. Neuropsychopharmacology. 2004 Feb;29(2):417-26. doi: 10.1038/sj.npp.1300340. Neuropsychopharmacology. 2004. PMID: 14583744 Clinical Trial.

4

Interictal SPECT in patients with mesial temporal lobe epilepsy and psychosis: a case-control study.

Guarnieri R, Wichert-Ana L, Hallak JE, Velasco TR, Walz R, Kato M, Alexandre V Jr, Terra-Bustamante VC, Bianchin MM, Zuardi AW, Deakin JF, Sakamoto AC. Guarnieri R, et al. Among authors: zuardi aw. Psychiatry Res. 2005 Jan 30;138(1):75-84. doi: 10.1016/j.pscychresns.2004.10.003. Psychiatry Res. 2005. PMID: 15708303

5

Electroconvulsive therapy for coexistent schizophrenia and obsessive-compulsive disorder.

Chaves MP, Crippa JA, Morais SL, Zuardi AW. Chaves MP, et al. Among authors: zuardi aw. J Clin Psychiatry. 2005 Apr;66(4):542-3. doi: 10.4088/jcp.v66n0420c. J Clin Psychiatry. 2005. PMID: 15816802 No abstract available.

6

Duloxetine in the treatment of panic disorder.

Crippa JA, Zuardi AW. Crippa JA, et al. Among authors: zuardi aw. Int J Neuropsychopharmacol. 2006 Oct;9(5):633-4. doi: 10.1017/S1461145705006206. Epub 2005 Nov 17. Int J Neuropsychopharmacol. 2006. PMID: 16288682 Free article. No abstract available.

7

Cannabidiol monotherapy for treatment-resistant schizophrenia.

Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA. Zuardi AW, et al. J Psychopharmacol. 2006 Sep;20(5):683-6. doi: 10.1177/0269881106060967. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401651 Clinical Trial.

8

Duloxetine in the treatment of social anxiety disorder.

Crippa JA, Filho AS, Freitas MC, Zuardi AW. Crippa JA, et al. Among authors: zuardi aw. J Clin Psychopharmacol. 2007 Jun;27(3):310. doi: 10.1097/01.jcp.0000270088.09415.6f. J Clin Psychopharmacol. 2007. PMID: 17502786 No abstract available.

9

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.

Zuardi AW. Zuardi AW. Braz J Psychiatry. 2008 Sep;30(3):271-80. doi: 10.1590/s1516-44462008000300015. Braz J Psychiatry. 2008. PMID: 18833429 Free article. Review.

10

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R, Seal M, Surguladze SA, O'Carrol C, Atakan Z, Zuardi AW, McGuire PK. Fusar-Poli P, et al. Among authors: zuardi aw. Arch Gen Psychiatry. 2009 Jan;66(1):95-105. doi: 10.1001/archgenpsychiatry.2008.519. Arch Gen Psychiatry. 2009. PMID: 19124693 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters